Immune Therapeutics, Inc. Information on LDN and MENK Providing information for Lodonal, low dose naltrexone and MENK

Trials Studies. Low Dose Naltrexone US. American Hospitals and Resorts. Hubei Qianjiang Pharmaceutical Company. Immune Therapeutics, Inc. Received Minutes From FDA. For the Treatment for Crohns. Immune Therapeutics, Inc. Announces First Sales and Shipment of Lodonal;. Receives Trademark and Patent Approval. From Federal Republic of Nigeria. Exclusive Agreement for Sale of Lodonal in Kenya. Valued at Over 31 Million. NAFDAC Approval for Marketing and Distribution of Lodonal. Using LDN and MENK.

OVERVIEW

This web site immunetherapeutics.com presently has an average traffic classification of zero (the lower the more traffic). We have researched nineteen pages inside the web page immunetherapeutics.com and found twelve websites associating themselves with immunetherapeutics.com. There are one contacts and locations for immunetherapeutics.com to help you communicate with them. There are four public communication sites owned by immunetherapeutics.com. This web site immunetherapeutics.com has been online for six hundred and seventy weeks, two days, eleven hours, and forty minutes.
Pages Analyzed
19
Links to this site
12
Contacts
1
Locations
1
Social Links
4
Online Since
Aug 2012

IMMUNETHERAPEUTICS.COM RANKINGS

This web site immunetherapeutics.com is seeing variant quantities of traffic all over the year.
Traffic for immunetherapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for immunetherapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for immunetherapeutics.com

Date Range

All time
This Year
Last Year
Last Month

IMMUNETHERAPEUTICS.COM HISTORY

This web site immunetherapeutics.com was first submitted to the registrar on August 17, 2012. This domain will expire on the date of August 17, 2014. As of today, it is six hundred and seventy weeks, two days, eleven hours, and forty minutes young.
REGISTERED
August
2012
EXPIRED
August
2014

PERIOD OF EXISTANCE

12
YEARS
10
MONTHS
3
DAYS

LINKS TO BUSINESS

The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies - QualityStocks is Covering the Small-Cap Micro-Cap World and Putting the Quality back in Stocks!

Covering Micro-Cap and Small-Cap Companies. Our writers and journalists keep investors up to date with the latest news from around the markets. The QualityStocks Blog is another extension of our commitment to help the investment community discover emerging companies that offer excellent growth potential. As demand increases, graphite prices projected to continue rising in 2018.

Top Stock Market Investing NEWS Best Stocks to Invest in Now

Investing Strategies Newsletter and Trading Alerts Service. Undervalued Medical Stocks Infusion Systems Medical Products Stock Undervalued Medical Stocks RMS Medical Products, Inc. Medical Products Stock Expands To Artificial Intelligence In Cancer Research.

WHAT DOES IMMUNETHERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of immunetherapeutics.com Mobile Screenshot of immunetherapeutics.com Tablet Screenshot of immunetherapeutics.com

CONTACTS

Buydomains.com

This Domain For Sale World Wide 339 222 5132

738 Main Street, #389

Waltham, MA, 02451

United States

IMMUNETHERAPEUTICS.COM HOST

Our web crawlers found that a single root page on immunetherapeutics.com took two thousand two hundred and thirty-four milliseconds to load. We identified a SSL certificate, so therefore our parsers consider immunetherapeutics.com secure.
Load time
2.234 seconds
SSL
SECURE
Internet Address
67.222.47.241

NAME SERVERS

ns.buydomains.com
this-domain-for-sale.com

SERVER OPERATING SYSTEM AND ENCODING

I revealed that immunetherapeutics.com is utilizing the nginx/1.12.2 operating system.

TITLE

Immune Therapeutics, Inc. Information on LDN and MENK Providing information for Lodonal, low dose naltrexone and MENK

DESCRIPTION

Trials Studies. Low Dose Naltrexone US. American Hospitals and Resorts. Hubei Qianjiang Pharmaceutical Company. Immune Therapeutics, Inc. Received Minutes From FDA. For the Treatment for Crohns. Immune Therapeutics, Inc. Announces First Sales and Shipment of Lodonal;. Receives Trademark and Patent Approval. From Federal Republic of Nigeria. Exclusive Agreement for Sale of Lodonal in Kenya. Valued at Over 31 Million. NAFDAC Approval for Marketing and Distribution of Lodonal. Using LDN and MENK.

CONTENT

This web site has the following in the web site, "For the Treatment for Crohns." Our analyzers noticed that the web site also stated " Announces First Sales and Shipment of Lodonal;." The Website also said " Receives Trademark and Patent Approval. From Federal Republic of Nigeria. Exclusive Agreement for Sale of Lodonal in Kenya. Valued at Over 31 Million. NAFDAC Approval for Marketing and Distribution of Lodonal."

SIMILAR WEB PAGES

Immunetic Lifesciences

Stringent technology based systems and process have been put into effect to produce SPF Embryonated Eggs.

Immunetics Immunetics

Names John Yonkin as CEO. SeraCare and Immunetics receive NIH Grant for Recent HIV Infection Rapid Test and Incidence Panels. Dedicated to health through science.

My Breast Cancer Blog

Sunday, October 8, 2017. Nine years ago today I received my original breast cancer diagnosis. I remember some parts of that day with amazing clarity. I have no memory of what occurred after I left work that day. Sunday, August 20, 2017. For some time since my mastectomy I have experienced itching on my right boob, i.

Immune to Iocane Music and Musings of Men of Action

Music and Musings of Men of Action. Everyone likes the Muppets right? Well, I think everyone should. But his legacy lives on in the Muppets, who are back in a brand new movie.

Home - 3rd International Conference on Immune Tolerance

3rd International Conference on Immune Tolerance 2014. 28th - 30th September 2014 NH Grand Krasnapolsky. Download the Conference App! We are delighted to announce that the 3rd International Conference on Immune Tolerance. Has a dedicated Free App. Available on all Android and iOS devices! To learn more and for download instructions. VIEW THE CONFERENCE PROGRAMME NOW. University of Zurich, Switzerland. University of California, San Francisco, USA.